Hong Kong Drug Licence Applications and Acquisitions · RGYS|Global Licensing and Compliance Service Provider
Hong Kong pharmaceutical compliance · applications / acquisitions / ongoing maintenance Independent Third-Party Service Provider
HONG KONG DRUG LICENSING

What core value can Rengangyongsheng (Hong Kong) Limited (RGYS) provide during the entire application and approval process?

A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.

Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.

Drug Office, Department of Health Chinese Medicines Board

Q250 · Category E: Application Process and Approval Procedures (Q201-Q250)

📘 Regulatory basis

All our services are firmly grounded in a thorough understanding and precise application of the Pharmacy and Poisons Ordinance, the Chinese Medicine Ordinance, and all relevant codes of practice and international standards (such as GSDP and GMP).

📗 Drew Tang's recommendations

The consultancy team led by our founder, Mr Tang Shangyong (Drew Tang), is your assurance of success. We are not merely your consultants; we are your business partners. We firmly believe that your success is our greatest success. We are committed to supporting you at every step of the application process with the highest professional standards and a customer-first service ethos.

📕 Risk notice

Choosing an unprofessional or inexperienced consultant is one of the greatest investment risks. Poor advice or an inadequate document may delay your application by months or even lead to refusal, wasting all your investment and effort. In the specialist field of compliance, choosing the right partner is the first and most important business decision you will make.

Back to Category E: Application Process and Approval Procedures (Q201-Q250) Search more questions

YOUR NEXT STEP

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

Book a Project Assessment ↗